Tuesday, November 24, 2020 3:08:12 AM
Moderate to Severe cases is what they mention. Moderate Covid likely does not have you in in-patient treatment, but at home (like Musk and others) with self-use treatment materials (like an inhaler).
Severe cases, esp. with respiratory failure, will indeed have you in in-patient therapy with locally administered inhaled treatments in a fix inhaler (as opposed to a portable one)
So I believe that those purporting the high likelihood of an Inhaler for Aviptadil are right on in their assessment / expectations.
1 - https://www.prnewswire.com/news-releases/fda-grants-inhaled-use-ind-for-rlf-100-aviptadil-to-treat-patients-with-moderate-and-severe-covid-19-aiming-to-prevent-progression-to-respiratory-failure-301107288.html
2 - https://clinicaltrials.gov/ct2/show/NCT04360096
3 - https://www.bbc.com/news/world-us-canada-54948005
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM